UNSPSC 85252502: Diagnosis of malignant neoplasm on the cornea

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Cornea. Malignant neoplasm on the Cornea is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C69. 1

UNSPSC 85252502 Diagnosis of malignant neoplasm on the cornea is a Commodity code that shows limited relevance to recent state and local procurement activity. The three most recent opportunities posted under this code—a diagnostic imaging PACS system implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing pool at Santa Clara County Health System—do not align with corneal cancer diagnosis services. The San Mateo opportunity involves enterprise radiology and medical imaging infrastructure, the Birdville solicitation covers school-based special education evaluations and therapies, and the Santa Clara vehicle establishes a qualified vendor pool for temporary clinical staffing across multiple ancillary categories including diagnostic imaging and therapy services. None of these solicitations target pathology, oncology consultation, or corneal disease diagnosis as a primary service line.

The geographic spread of the recent activity spans California (San Mateo County and Santa Clara County) and Texas (Tarrant County), reflecting issuing bodies that include county health systems, public hospital networks, and independent school districts. The mismatch between the code's nominal scope and the actual work being solicited suggests that either the code was applied incorrectly by the issuing bodies or that state and local procurement activity under this specific Commodity code does not currently reflect its intended service line. Practitioners considering this code should verify code alignment with customer procurement staff before investing business development effort, as the recent posting history does not demonstrate active demand for corneal cancer diagnosis services under this designation.